Cepheid
Cepheid is dedicated to improving patient outcomes worldwide with fast, accurate tests for diseases like tuberculosis, HCV, and respiratory illnesses. They focus on global health initiatives, innovative diagnostic solutions, and providing accessible testing platforms to healthcare professionals and systems globally. Their GeneXpert® System is a flexible, scalable platform offering a broad test menu suitable for various healthcare settings, from core laboratories to near-patient applications. Cepheid emphasizes global public health through programs like the Global Access Program, ensuring access to high-quality diagnostic tests everywhere. The company supports healthcare providers, laboratory professionals, and health system administrators with education, resources, and tools to advance diagnostic capabilities and improve health outcomes.
Industries
Nr. of Employees
Very Large (1000+)
Patents
Integrated purification and measurement of DNA methylation and co-measurement of mutations and/or mRNA expression levels in an automated reaction cartridge
US-12539510-B2
View Details
Integrated purification and measurement of DNA methylation and co-measurement of mutations and/or mRNA expression levels in an automated reaction cartridge
US-12539510-B2
View DetailsProducts
Automated PCR-based diagnostic system
Instrument platform for automated molecular amplification and detection that supports scalable configurations for both core laboratory and near-patient environments and operates with modular assay formats.
Modular molecular assay cartridges for infectious diseases
Cartridge-format molecular assays targeting multiple infectious disease indications to enable pathogen detection and differentiation at the point of care or in laboratories.
Xpert® Xpress Strep A
A rapid PCR test for detection of Streptococcus A on the GeneXpert® Xpress system, designed for point-of-care testing.
Xpert® BCR-ABL Ultra p190
Sensitive and quantitative monitoring of BCR-ABL p190 and ABL mRNA in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL)
Xpert ® NPM1 Mutation
Automated test for quantifying the amount of mutant NPM1 mRNA transcripts (types A, B, and D in exon 12) as a ratio of NPM1 Mutation/ABL1 with high sensitivity
Xpert® Breast Cancer STRAT4
Standardized breast cancer ESR1/PGR/ERBB2/MKi67 mRNA biomarker assessment in less than two hours
Automated PCR-based diagnostic system
Instrument platform for automated molecular amplification and detection that supports scalable configurations for both core laboratory and near-patient environments and operates with modular assay formats.
Modular molecular assay cartridges for infectious diseases
Cartridge-format molecular assays targeting multiple infectious disease indications to enable pathogen detection and differentiation at the point of care or in laboratories.
Xpert® Xpress Strep A
A rapid PCR test for detection of Streptococcus A on the GeneXpert® Xpress system, designed for point-of-care testing.
Xpert® BCR-ABL Ultra p190
Sensitive and quantitative monitoring of BCR-ABL p190 and ABL mRNA in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL)
Xpert ® NPM1 Mutation
Automated test for quantifying the amount of mutant NPM1 mRNA transcripts (types A, B, and D in exon 12) as a ratio of NPM1 Mutation/ABL1 with high sensitivity
Xpert® Breast Cancer STRAT4
Standardized breast cancer ESR1/PGR/ERBB2/MKi67 mRNA biomarker assessment in less than two hours
Services
Programmatic support to expand access to diagnostic tests in global public-health settings, including deployment models and implementation support for low-resource environments.
On-site deployment services and workflow consulting to place molecular testing in near-patient settings and integrate test results into clinical care pathways.
Online and in-person educational content, implementation tools, and resources to support correct use of diagnostic assays and instruments.
Programmatic support to expand access to diagnostic tests in global public-health settings, including deployment models and implementation support for low-resource environments.
On-site deployment services and workflow consulting to place molecular testing in near-patient settings and integrate test results into clinical care pathways.
Online and in-person educational content, implementation tools, and resources to support correct use of diagnostic assays and instruments.
Expertise Areas
- Point-of-care and near-patient molecular diagnostics
- Molecular infectious-disease testing (tuberculosis, hepatitis C, respiratory pathogens)
- Deployment of diagnostics in low-resource and public-health settings
- Clinical workflow integration and health IT connectivity
Key Technologies
- Automated PCR-based molecular diagnostics
- Point-of-care/near-patient testing platforms
- Cartridge-format multiplex molecular assays
- Clinical workflow connectivity and laboratory informatics
News & Updates
Event details
Event details
Event details
Learn how POC diagnostics paired with substance use disorder treatment can improve Hep C infection outcomes, especially as HCV rates increase with opioid use.
Read about Cepheid's innovations deployed over 20 years to address infectious public health emergencies and their foundations for future preparedness.
An expert perspective on bacterial vaginosis, the most common vaginal infection, and strategies to reduce recurrence.
Event details
Event details
Event details
Learn how POC diagnostics paired with substance use disorder treatment can improve Hep C infection outcomes, especially as HCV rates increase with opioid use.
Read about Cepheid's innovations deployed over 20 years to address infectious public health emergencies and their foundations for future preparedness.
An expert perspective on bacterial vaginosis, the most common vaginal infection, and strategies to reduce recurrence.